Investors in GlaxoSmithKline plc (NYSE: GSK) saw new options become available today, for the January 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options chain for the new January …
Forbes9mon
On July 14 the stock rating was upgraded from “” to “Buy” in a report issued by Jefferies. On February 26 analysts at Cantor Fitzgerald started covering GSK with a rating of “Hold”. On January 27, 2016 the stock rating was set at “Buy ...
A number of other equities analysts have also recently issued reports on the stock. ValuEngine lowered GlaxoSmithKline PLC from a "buy" rating to a "hold" rating in a research report on Friday, June 2nd. Shore Capital reissued a hold rating …
GlaxoSmithKline (GSK) says that federal regulators had cleared a combination of its drugs to treat melanoma, sending GSK stock modestly higher in Thursday ... Sclerosis Drug The drugs received accelerated approval from the FDA after …
News articles about GlaxoSmithKline PLC (NYSE:GSK) have trended positive on Tuesday, according to Accern. Ledyard National Bank now owns 10,362 shares of the pharmaceutical company's stock valued at $447,000 after buying an …
Buz Investors GlaxoSmithKline PLC One sector that is known for large gross margins is the healthcare sector. Typically, high-gross-margin businesses are not looked at by dividend investors, the reason being that there is often no dividend. …
Shares of GlaxoSmithKline plc (LON:GSK) have been assigned a consensus rating of "Hold" from the twenty-three brokerages that are now covering the firm, Marketbeat.com reports. Over the last 30 and 90 trading days the company …
GlaxoSmithKline PLC (LON:GSK) had its stock rating noted as Neutral by analysts at Natixis. Natixis currently has a GBX 1470.00 target price on the 67.33 billion GBP market cap company or 6.29 % upside potential. This was shown in …
Glaxo's rise in May was precipitated by two catalysts. First, the drugmaker's new managerial team, headed by CEO Emma Walmsley (who took over in March), has been indicating that they might be open to accelerating the company's …